Posted by Michael Wonder on 03 Jul 2024
Approval of newest Alzheimer’s drug will accelerate new era of treatment
2 July 2024 - With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.
The approval Tuesday of Eli Lilly’s new Alzheimer’s drug will hasten the transformation of treatment of the dementia-causing condition.
